Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
42,194,093
-
Total 13F shares
-
13,061,656
-
Share change
-
+299,763
-
Total reported value
-
$378,528,053
-
Price per share
-
$28.98
-
Number of holders
-
44
-
Value change
-
+$8,240,890
-
Number of buys
-
27
-
Number of sells
-
16
Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS) as of Q2 2021
As of 30 Jun 2021,
Tarsus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TARS) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,061,656 shares.
The largest 10 holders included
Vivo Capital, LLC, RTW INVESTMENTS, LP, Cormorant Asset Management, LP, FRAZIER MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, TimesSquare Capital Management, LLC, COWEN AND COMPANY, LLC, Jefferies Group LLC, BlackRock Inc., and VANGUARD GROUP INC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.